Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard M Katzenstein

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
NPJ Precision Oncology|May 22, 2021
Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic targetNathan D Seligson, Richard D Maradiaga, Colin M Stets, et al.
Journal of Pediatric Surgery|March 13, 2003
Increased microvascular density predicts relapse in Wilms' tumorLisa P Abramson, Paul E Grundy, Alfred W Rademaker, et al.
Pediatric Blood & Cancer|February 4, 2012
Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomasLouis Rapkin, Muna Qayed, Pam Brill, et al.
Critical Care Medicine|February 27, 2009
Extracorporeal life support for support of children with malignancy and respiratory or cardiac failure: The extracorporeal life support experienceKenneth W Gow, Kurt F Heiss, Mark L Wulkan, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|December 19, 2009
NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic/hepatic primaryBahig M Shehata, Charlotte K Steelman, Carlos R Abramowsky, et al.
Cancer|October 9, 2009
Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology GroupHoward M Katzenstein, Kay W Chang, Mark Krailo, et al.
The Oncologist|October 17, 2023
Evaluating Oncologists' Practice Patterns and Decision-Making in Locally Advanced or Metastatic Urothelial Carcinoma: The US Physician PARADIGM StudyShilpa Gupta, Halley Costantino, Chiemeka Ike, et al.
Pediatric Blood & Cancer|December 27, 2019
A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumorsMuna Qayed, Thomas Cash, Mourad Tighiouart, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|October 12, 2011
Colorectal adenocarcinoma: a pediatric case review with a focus on mismatch repair gene mutations and E-cadherin expressionRaul S Gonzalez, Sarah C Shulman, Howard M Katzenstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastomaHoward M Katzenstein, Susan L Cohn, Richard M Shore, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
NPJ Precision Oncology|May 22, 2021
Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic targetNathan D Seligson, Richard D Maradiaga, Colin M Stets, et al.
Journal of Pediatric Surgery|March 13, 2003
Increased microvascular density predicts relapse in Wilms' tumorLisa P Abramson, Paul E Grundy, Alfred W Rademaker, et al.
Pediatric Blood & Cancer|February 4, 2012
Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomasLouis Rapkin, Muna Qayed, Pam Brill, et al.
Critical Care Medicine|February 27, 2009
Extracorporeal life support for support of children with malignancy and respiratory or cardiac failure: The extracorporeal life support experienceKenneth W Gow, Kurt F Heiss, Mark L Wulkan, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|December 19, 2009
NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic/hepatic primaryBahig M Shehata, Charlotte K Steelman, Carlos R Abramowsky, et al.
Cancer|October 9, 2009
Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology GroupHoward M Katzenstein, Kay W Chang, Mark Krailo, et al.
The Oncologist|October 17, 2023
Evaluating Oncologists' Practice Patterns and Decision-Making in Locally Advanced or Metastatic Urothelial Carcinoma: The US Physician PARADIGM StudyShilpa Gupta, Halley Costantino, Chiemeka Ike, et al.
Pediatric Blood & Cancer|December 27, 2019
A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumorsMuna Qayed, Thomas Cash, Mourad Tighiouart, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|October 12, 2011
Colorectal adenocarcinoma: a pediatric case review with a focus on mismatch repair gene mutations and E-cadherin expressionRaul S Gonzalez, Sarah C Shulman, Howard M Katzenstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastomaHoward M Katzenstein, Susan L Cohn, Richard M Shore, et al.
Pageof 8